OpenAlex identifies Yunpeng Chen (ORCID 0000-0002-9830-8980) with 110 works, 10,295 citations, and h-index 32, concentrated in computer science, AI, pattern recognition, and machine learning . His citation trajectory is unusual: annual citations rose from ~4 in 2015 to ~1,600/year by 2025, indicating his architectural contributions became foundational as transformers displaced CNNs.
Chen's most cited work, T2T-ViT (3,166 cites), solved the critical problem of training Vision Transformers from scratch without massive pre-training . As first author he produced Octave Convolution (916 cites), which exploits frequency-domain redundancy in feature maps for efficiency , Dual Path Networks (852 cites), unifying ResNet and DenseNet topologies , and Graph-Based Global Reasoning Networks (625 cites) . He also contributed to attention mechanisms (AΒ²-Nets, 536 cites) , efficient mobile networks , and recent large-scale generative models (Seedream 4.0, 320 cites in months) .
Strengths: repeated first-authorship of benchmark-validated architectural innovations at top venues (ICCV/CVPR/NeurIPS-adjacent), rigorous ablation-driven engineering, and demonstrated influence across both CNN and transformer eras. Caveats: bibliometric strength is inflated by the hyper-cited transformer field (citation counts in AI grow faster than in biomedical fields, limiting cross-disciplinary comparison); most results are reported on ImageNet-family benchmarks where progress correlates strongly with compute and data scale rather than novel theory; authorship positions on flagship works are often middle rather than first (T2T-ViT, Seedream 4.0); and the name is heavily conflated in OpenAlex with at least nine other "Yunpeng Chen"/"Pengyun Chen" entities, including a biomedical-profile author (A5076686558, 202 works), so any claim about this author must be anchored to ORCID 0000-0002-9830-8980. Confidence: high on bibliometrics (single authoritative source), moderate on qualitative scientific judgment.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.